Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Decision Making clinical trials

5 of 9 indexed Decision Making trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Decision Making: 9 US clinical trials tracked, 5 recruiting.

Decision Making is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Chestnut Health Systems, running 2 of these trials.

Enrollment posture brief

Registry condition decision-making

OPEN 5 | RECR 56% | LATE 0 | EARLY 0 | RANK #1916 | SPON 2

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Decision Making (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Decision Making

Decision Making lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Decision Making on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Decision Making is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Decision Making research.

    Chestnut Health Systems accounts for 2 of 9 trials (22.2%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Decision Making enrolment sits around 120 participants.

    Median target enrolment is 120 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Decision Making research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Decision Making records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

End-stage renal disease treatment options Other
1 trials
Target Prevalence Behavioral
1 trials
Simulated Second Reader AI Behavioral
1 trials
End-of-Life / Advanced Care Decision Aid Behavioral
1 trials
IDECIDE-HOSPICE Other
1 trials
Data products Other
1 trials
Co-Design Sessions (CDS) Other
1 trials
High Touch Strategy Behavioral
1 trials

US sites by state

Facility locations filed on Decision Making trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Oregon 2 trials
Colorado 2 trials
New York 1 trials
New Jersey 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Decision Making page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Decision Making condition card totals 9 registered trials; most-linked intervention End-stage renal disease treatment options; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.